Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development. Working with the AI company will help Sanofi “go to market faster with ...

Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent ...

Sanofi’s vaccines business is interested in partners who will share in the pursuit of innovation and the company’s drive for excellence while becoming a part of its market success story.